Furin overexpression suppresses tumor growth and predicts a better postoperative disease-free survival in hepatocellular carcinoma

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Huang, Ya Hui ^a   Lin, Kwang Huei ^b   Liao, Chen Hsin ^b   Lai, Ming Wei ^c   Tseng, Yi Hsin ^b   Yeh, Chau Ting ^a,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c Chang Gung Children Hospital   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DECANOYL ARGINYLVALYLLYSYLARGINYL CHLOROMETHYLKETONE; ENZYME INHIBITOR; FURIN; KETONE DERIVATIVE; PROPROTEIN CONVERTASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GROWTH RATE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PREDICTION; PROTEIN EXPRESSION; SUBCUTANEOUS TISSUE TUMOR; TUMOR XENOGRAFT;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DISEASE-FREE SURVIVAL; FEMALE; FURIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; POSTOPERATIVE CARE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 84863677003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040738     Document Type: Article

References (39)

1. Molloy SS, Anderson ED, Jean F, Thomas G, (1999) Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis. Trends Cell Biol 9: 28-35.
2. Nakayama K, (1997) Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327 (Pt 3): 625-635.
3. Thomas G, (2002) Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3: 753-766.
4. Bassi DE, Mahloogi H, Klein-Szanto AJ, (2000) The proprotein convertases furin and PACE4 play a significant role in tumor progression. Mol Carcinog 28: 63-69.
5. Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ, (2005) Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol Carcinog 44: 151-161.
6. Blanchette F, Day R, Dong W, Laprise MH, Dubois CM, (1997) TGFbeta1 regulates gene expression of its own converting enzyme furin. J Clin Invest 99: 1974-1983.
7. de Cicco RL, Bassi DE, Benavides F, Conti CJ, Klein-Szanto AJ, (2007) Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression. Mol Carcinog 46: 654-659.
8. Page RE, Klein-Szanto AJ, Litwin S, Nicolas E, Al-Jumaily R, et al. (2007) Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol 29: 289-299.
9. Cheng M, Watson PH, Paterson JA, Seidah N, Chretien M, et al. (1997) Pro-protein convertase gene expression in human breast cancer. Int J Cancer 71: 966-971.
10. Bassi DE, Mahloogi H, Al-Saleem L, Lopez de Cicco R, Ridge JA, et al. (2001) Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog 31: 224-232.
11. Mbikay M, Sirois F, Yao J, Seidah NG, Chretien M, (1997) Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer 75: 1509-1514.
12. Schalken JA, Roebroek AJ, Oomen PP, Wagenaar SS, Debruyne FM, et al. (1987) fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas. J Clin Invest 80: 1545-1549.
13. Mercapide J, Lopez de Cicco R, Bassi DE, Castresana JS, Thomas G, et al. (2002) Inhibition of furin-mediated processing results in suppression of astrocytoma cell growth and invasiveness. Clin Cancer Res 8: 1740-1746.
14. Bassi DE, Lopez de Cicco R, Mahloogi H, Zucker S, Thomas G, et al. (2001) Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc Natl Acad Sci U S A 98: 10326-10331.
15. Coppola JM, Bhojani MS, Ross BD, Rehemtulla A, (2008) A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness. Neoplasia 10: 363-370.
16. Khatib AM, Siegfried G, Chretien M, Metrakos P, Seidah NG, (2002) Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am J Pathol 160: 1921-1935.
17. Bassi DE, Mahloogi H, Lopez de Cicco R, Klein-Szanto A, (2003) Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 162: 439-447.
18. Chen RN, Huang YH, Lin YC, Yeh CT, Liang Y, et al. (2008) Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines. Endocrinology 149: 3817-3831.
19. Huang YH, Liao CH, Chen RN, Liao CJ, Lin KH, (2010) Human testicular orphan receptor 4 enhances thyroid hormone receptor signaling. J Cell Physiol 222: 347-356.
20. Angliker H, Wikstrom P, Shaw E, Brenner C, Fuller RS, (1993) The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast. Biochem J 293 (Pt 1): 75-81.
21. Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, et al. (1992) Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. Embo J 11: 2407-2414.
22. Yeh CT, Kuo CJ, Lai MW, Chen TC, Lin CY, et al. (2009) CD133-positive hepatocellular carcinoma in an area endemic for hepatitis B virus infection. BMC Cancer 9: 324.
23. Schnater JM, Bruder E, Bertschin S, Woodtli T, de Theije C, et al. (2006) Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice. J Hepatol 45: 377-386.
24. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R, (1995) Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 270: 10618-10624.
25. Cao J, Rehemtulla A, Pavlaki M, Kozarekar P, Chiarelli C, (2005) Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase. J Biol Chem 280: 10974-10980.
26. Aleem E, Nehrbass D, Klimek F, Mayer D, Bannasch P, (2011) Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis. Toxicol Pathol 39: 524-543.
27. Liu M, Lee DF, Chen CT, Yen CJ, Li LY, et al. (2012) IKKalpha activation of NOTCH links tumorigenesis via FOXA2 suppression. Mol Cell 45: 171-184.
28. Llovet JM, Bruix J, (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48: 1312-1327.
29. Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, et al. (2000) Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89: 2274-2281.
30. Masaki T, Shiratori Y, Rengifo W, Igarashi K, Matsumoto K, et al. (2000) Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats. Hepatology 32: 711-720.
31. Maeda S, Chang L, Li ZW, Luo JL, Leffert H, et al. (2003) IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity 19: 725-737.
32. Guo XZ, Shao XD, Liu MP, Xu JH, Ren LN, et al. (2002) Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J Gastroenterol 8: 1059-1062.
33. Chipuk JE, Bhat M, Hsing AY, Ma J, Danielpour D, (2001) Bcl-xL blocks transforming growth factor-beta 1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells. J Biol Chem 276: 26614-26621.
34. Ewen ME, Oliver CJ, Sluss HK, Miller SJ, Peeper DS, (1995) p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest. Genes Dev 9: 204-217.
35. Pardali K, Moustakas A, (2007) Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775: 21-62.
36. de Vos L, Declercq J, Rosas GG, van Damme B, Roebroek A, et al. (2008) MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice. Int J Oncol 32: 1073-1083.
37. Zhang H, Ozaki I, Mizuta T, Yoshimura T, Matsuhashi S, et al. (2004) Transforming growth factor-beta 1-induced apoptosis is blocked by beta 1-integrin-mediated mitogen-activated protein kinase activation in human hepatoma cells. Cancer Sci 95: 878-886.
38. Sun X, Essalmani R, Seidah NG, Prat A, (2009) The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model. Mol Cancer 8: 73.
39. Su LK, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670.